IP Library Granted Patent US 10,426,533
Granted Patent B2
US 10,426,533 · App. 13/888,249 · Granted Oct 1, 2019

Fenestrated implant

Inventors: Richard G. Mauldin (Erie, CO); Scott A. Yerby (Montara, CA); Mark A. Reiley (Washington, DC); Bret W. Schneider (Morgan Hill, CA)
Assignee: SI-Bone Inc.
A61B17/84A61B17/68A61B17/7055A61B17/1604A61B17/1664A61B17/1671A61B17/1697A61B17/1757A61B17/8897A61F2002/30995
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,533
App. No.
13/888,249
Granted
Oct 1, 2019
Kind
B2
Abstract

The present invention relates generally to implants used in medical procedures such as bone fixation or fusion. More specifically, this application relates to fenestrated implants used in bone fixation or fusion.

Claims (22)

1. An implant for bone fixation, the implant comprising:

an elongate body having a longitudinal axis, a distal end, a proximal end, a rectilinear cross section transverse to the longitudinal axis having three or four sides, and a plurality of faces, each of the plurality of faces formed from a wall with a thickness between 1 mm and 5 mm in thickness, and each face having a width and a plurality of fenestrations, the plurality of fenestrations each having a diameter that is between about 0.2 to about 0.5 of the width of its associated face, the elongate body having a central lumen located along the longitudinal axis and configured to receive a guide pin, wherein each of the plurality of fenestrations reach and provide access to the central lumen, wherein a concentration or number of fenestrations is higher in a distal half of the elongate body than in a proximal half, wherein the distal end of the elongate body is tapered to facilitate implantation into the bone, and wherein the elongate body has a bending strength or a shear strength of at least 0.5 relative to a reference elongate body with identical dimensions and material composition but without any fenestrations.

2. The implant of claim 1 , wherein the distal end of the elongate body is formed into one or more cutting edges.

3. The implant of claim 1 , wherein the fenestrations are located on a distal portion of the elongate body that is configured to be implanted within the sacrum of a patient while the proximal portion of the elongate body that is configured to be implanted within the ilium is free from fenestrations.

4. The implant of claim 1 , wherein the fenestrations are arranged in a staggered pattern.

5. The implant of claim 1 , further comprising a cap on the proximal end of the elongate body, the cap having a hole sized to receive a guide pin.

6. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are porous.

7. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are roughened.

8. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are treated with a plasma coating.

9. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are coated with a biologic aid.

10. The implant of claim 9 , wherein the biologic aid is a bone morphogenetic protein.

11. An implant for bone fixation, the implant comprising:

an elongate body having a longitudinal axis, a distal end, a proximal end, a rectilinear cross section transverse to the longitudinal axis having three or four sides, and a plurality of faces, each of the plurality of faces having a width and a plurality of fenestrations, the plurality of fenestrations each having a diameter that is between about 0.2 to about 0.5 of the width of its associated face, the elongate body having a central lumen located along the longitudinal axis and configured to receive a guide pin, wherein each of the plurality of fenestrations reach and provide access to the central lumen, wherein a concentration or number of fenestrations is higher in a distal half of the elongate body than in a proximal half, wherein the distal end of the elongate body is tapered to facilitate implantation into the bone, and wherein the elongate body has a bending strength or a shear strength of at least 0.5 relative to a reference elongate body with identical dimensions and material composition but without any fenestrations.

12. The implant of claim 11 , wherein the distal end of the elongate body is formed into one or more cutting edges.

13. The implant of claim 11 , wherein the fenestrations are located on a distal portion of the elongate body that is configured to be implanted within the sacrum of a patient while the proximal portion of the elongate body that is configured to be implanted within the ilium is free from fenestrations.

14. The implant of claim 11 , wherein the fenestrations are arranged in a staggered pattern.

15. The implant of claim 11 , further comprising a cap on the proximal end of the elongate body, the cap having a hole sized to receive a guide pin.

16. The implant of claim 11 , wherein the elongate body has an inner surface and an outer surface that are porous.

17. The implant of claim 11 , wherein the elongate body has an inner surface and an outer surface that are roughened.

18. The implant of claim 11 , wherein the elongate body has an inner surface and an outer surface that are treated with a plasma coating.

19. The implant of claim 11 , wherein the elongate body has an inner surface and an outer surface that are coated with a biologic aid.

20. The implant of claim 19 , wherein the biologic aid is a bone morphogenetic protein.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD., AS COLLATERAL AGENT)
To: SI-BONE, INC.
Reel/Frame 057182/0104 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL AT REEL/FRAME NO. 043975/0669 Recorded May 29, 2020
From: BIOPHARMA CREDIT INVESTMENTS IV SUB LP
To: SI-BONE, INC.
Reel/Frame 052794/0423 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 29, 2020
From: SI-BONE, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 052795/0289 →
SECURITY INTEREST Recorded Oct 27, 2017
From: SI-BONE, INC.
To: BIOPHARMA CREDIT INVESTMENTS IV SUB LP
Reel/Frame 043975/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2013
From: MAULDIN, RICHARD G.; YERBY, SCOTT A.; REILEY, MARK A.; SCHNEIDER, BRET W.
To: SI-BONE INC.
Reel/Frame 031634/0931 →
Continuity (2)
Provisional Application 61642681 · May 4, 2012
Related Publication 20130296953A1 · Nov 7, 2013
Cited By (13)
US 12,201,330 US 12,213,886 US 12,220,326 US 12,239,543 US 12,349,944 US 12,427,028 US 12,433,733 US 12,453,563 US 12,458,413 US 12,616,587 US 12,636,165 US 12,661,239 US 12,708,415